Hvað þýðir "Hreinsa"?
Dýrið ber ekki stökkbreytinguna. Það mun ekki þróa sjúkdóminn og mun ekki gefa það áfram.
Discover the benefits of a DNA test for Bardet-Biedl Syndrome 4 in dogs, a crucial tool for responsible pet owners. This genetic condition can lead to serious health issues, including obesity and vision problems. By identifying whether your dog carries the BBS4 mutation, you can take proactive steps to manage their health. Early detection through DNA testing allows for tailored care and informed breeding decisions. Ensure your furry friend lives a happy, healthy life by understanding their genetic risks. Invest in a reliable DNA test today to safeguard your dog's well-being. Learn more about Bardet-Biedl Syndrome 4 testing and its importance in canine health.
Bardet-Biedl Syndrome 4 (BBS4) in dogs is a genetic condition that can lead to a range of health issues, including obesity, vision problems, and kidney dysfunction. A DNA test for BBS4 helps identify carriers and affected individuals, allowing for informed breeding decisions. Early detection through genetic testing can improve management strategies and enhance the quality of life for affected dogs. Responsible breeders can use this information to reduce the prevalence of the syndrome in future generations. Overall, DNA testing plays a crucial role in canine health and well-being.
Þetta DNA próf er innifalið frá pakkanum okkar Basic — og er líka hluti af pökkunum Basic, Standard, Advanced, Complete.
Skoða DNA prófunarpakka →Bardet-Biedl Syndrome 4 (BBS4) is a genetic disorder that affects various systems in the body of affected dogs. It is part of a group of conditions known as Bardet-Biedl Syndromes, which are characterized by a range of symptoms that can include obesity, retinal degeneration, polydactyly, and kidney abnormalities. This syndrome is caused by mutations in specific genes that play a critical role in cellular function and development.
BBS4 is linked to mutations in the BBS4 gene, which is responsible for encoding a protein involved in the functioning of cilia—tiny hair-like structures that project from the surface of cells. Cilia play a crucial role in various cellular processes, including signaling pathways that regulate growth and development. When mutations occur in the BBS4 gene, it can lead to improper functioning of these cilia, resulting in the clinical manifestations associated with the syndrome.
Dogs affected by Bardet-Biedl Syndrome 4 can exhibit a range of clinical signs. One of the most common symptoms is obesity, which may develop early in life and can be challenging to manage. Additionally, affected dogs often experience progressive retinal degeneration, leading to vision impairment or blindness. Other potential symptoms include polydactyly, where dogs may have extra toes, and various kidney abnormalities that can affect renal function.
Diagnosing Bardet-Biedl Syndrome 4 typically involves a combination of clinical evaluation and genetic testing. DNA testing can identify mutations in the BBS4 gene, confirming the diagnosis. This genetic test is a valuable tool for breeders and pet owners, as it can help determine whether a dog carries the genetic mutation associated with the syndrome, allowing for informed breeding decisions and management of affected animals.
Currently, there is no cure for Bardet-Biedl Syndrome 4, and management focuses on alleviating symptoms and improving the quality of life for affected dogs. Weight management through a balanced diet and regular exercise is crucial to combat obesity. Regular veterinary check-ups are essential for monitoring kidney function and addressing any eye-related issues that may arise due to retinal degeneration. Supportive care and early intervention can significantly enhance the well-being of dogs diagnosed with this condition.
Bardet-Biedl Syndrome 4 is a complex genetic disorder that poses various health challenges for affected dogs. Understanding the genetic basis, clinical signs, and management strategies is essential for owners and breeders to ensure the best possible care for these animals. Genetic testing plays a vital role in the early diagnosis and responsible breeding practices, ultimately contributing to the health and longevity of dogs at risk for this syndrome.
Dýrið ber ekki stökkbreytinguna. Það mun ekki þróa sjúkdóminn og mun ekki gefa það áfram.
Nei. Dýrið er almennt heilbrigt en getur sent stökkbreytinguna til þess afkvæmi.
Það ber tvö stökkbreytt eintök. Búist er við klínískum einkennum eftir því sjúkdómnum. Það ætti ekki að rækta það.
Sumir sjúkdómar eru kyntengdir, þannig að tjáning þeirra er mismunandi eftir því kynlíf dýra.
This DNA test detects the mutation associated with Bardet-Biedl Syndrome 4 in order to identify clear, carrier, or at-risk animals.
DNA próf hjálpar ræktendum að skipuleggja öruggari pörun og draga úr hættu á að stökkbreytingin berist til afkvæma.
Erfðastillingin sem tilkynnt er um fyrir þetta próf er Autosomal Recessive.
This test analyses the mutation BBS4 c.58A>T.
Ekki endilega. Túlkun fer eftir erfðamynstri og arfgerðinni sem myndast.
Chew Tracy, Haase Bianca, Bathgate Roslyn, Willet Cali E, Kaukonen Maria K, Mascord Lisa J, Lohi Hannes T, Wade Claire M. A Coding Variant in the Gene Bardet-Biedl Syndrome 4 (BBS4) Is Associated with a Novel Form of Canine Progressive Retinal Atrophy. G3 (Bethesda). 2017 Jul 5;7(7):2327-2335. doi: 10.1534/g3.117.043109.
Þitt næði, þitt val
Við notum nauðsynlegar vafrakökur til að keyra vefsíðuna. Valfrjálsar vafrakökur (svo sem innbyggðar efnisveitur) eru sjálfgefnar óvirkar og aðeins virkar ef þú samþykkir. Þú getur breytt vali þínu hvenær sem er með því að nota „Cookies“ hnappinn.
Nauðsynlegt fyrir kjarnaeiginleika og öryggi. Alltaf virkt.
Bætir eiginleika eins og vistun vals eða innfellingar án auglýsinga.
Hjálpar okkur að skilja síðunotkun. Sjálfgefið óvirkt.
Auglýsingar/rakningar á vefsvæðum (sum vídeó/kortum innfelld). Sjálfgefið óvirkt.